We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
0
0 active
Approvals
1
Total approvals
Agencies
Regulatory bodies
Founded
N/A
No trial phase data available
No trial data available
FDA
Food and Drug Administration
- A new market outlook covering 2026-2030 projects continued growth in ADME toxicology testing demand, driven by expansion of the global pharmaceutical industry. - North America was the largest regional market in 2025, while Asia-Pacific is expected to be the fastest-growing region through the forecast period. - European pharmaceutical production reached EUR 390.0 billion ($422.8 billion) in 2023, up from EUR 363.3 billion ($393.9 billion) in 2022, according to EFPIA. - Evotec SE launched the Cyprotex e-Store in October 2023, an e-commerce platform providing online access to its ADME-Tox service portfolio.
